High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status.
Westermann F, Henrich KO, Wei JS, Lutz W, Fischer M, König R, Wiedemeyer R, Ehemann V, Brors B, Ernestus K, Leuschner I, Benner A, Khan J, Schwab M.
Westermann F, et al. Among authors: ehemann v.
Clin Cancer Res. 2007 Aug 15;13(16):4695-703. doi: 10.1158/1078-0432.CCR-06-2818. Epub 2007 Jul 25.
Clin Cancer Res. 2007.
PMID: 17652624